BUDGET IMPACT ANALYSIS OF THE USE OF ASPART INSULIN DURING HOSPITALIZATION OF PATIENTS WITH HYPERGLYCAEMIA IN ITALY

被引：0

作者：

Iannazzo, S. ^{[1
]}

Pradelli, L. ^{[1
]}

Montagnoli, R. ^{[2
]}

Militano, L. ^{[2
]}

机构：

[1] AdRes HE&OR, Turin, Italy

[2] Novo Nordisk Farmaceut Spa, Rome, Italy

来源：

VALUE IN HEALTH | 2011年 / 14卷 / 07期

关键词：

D O I：

10.1016/j.jval.2011.08.1327

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A475 / A476

页数：2

共 50 条

[21] A THREE YEARS BUDGET IMPACT ANALYSIS OF HEMANEXT IN ITALY
Marcellusi, A.
Marichal, A.
Leonardi, A.
VALUE IN HEALTH, 2022, 25 (12) : S127 - S127
[22] BUDGET IMPACT ANALYSIS OF VIACORAM FOR THE TREATMENT OF HYPERTENSION IN ITALY
Lanati, E. P.
Orlando, V. L.
Doratori, S.
VALUE IN HEALTH, 2016, 19 (07) : A644 - A644
[23] BUDGET IMPACT ANALYSIS OF TRIPLIAM FOR THE TREATMENT OF HYPERTENSION IN ITALY
Lanati, E. P.
Orlando, V. L.
VALUE IN HEALTH, 2015, 18 (07) : A384 - A384
[24] Cost impact analysis of mealtime fast-acting insulin aspart compared with insulin aspart in adults with Type 1 diabetes in the UK
Pollock, R. F.
Parekh, W.
Watcham, S.
Hallen, N.
DIABETIC MEDICINE, 2019, 36 : 166 - 166
[25] BIOLOGIC TREATMENTS FOR MODERATE TO SEVERE NAIVE PSORIATIC PATIENTS: A BUDGET IMPACT ANALYSIS IN ITALY
Povero, M.
Pradelli, L.
VALUE IN HEALTH, 2015, 18 (07) : A663 - A664
[26] A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy
Capri, Stefano
Migliore, A.
Loconsole, F.
Barbieri, Marco
JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 353 - 361
[27] BUDGET IMPACT ANALYSIS FOR THE USE OF DUPILUMAB IN PATIENTS WITH SEVERE ASTHMA IN COLOMBIA
Londono, S.
Saenz, S. A.
Avila, M. P.
VALUE IN HEALTH, 2022, 25 (01) : S62 - S62
[28] First experiences with the use of insulin aspart in diabetic patients treated with CSII regimen
Smahelová, A
Rusavy, Z
Koznarová, R
Loyková, V
Belobrádková, J
DIABETOLOGIA, 2004, 47 : A298 - A299
[29] Efficacy and Safety of Insulin Aspart 30 and Insulin Degludec/Aspart vs. Basal Insulin in Patients with Type 2 Diabetes: A Meta-analysis
Mishriky, Basem M.
Tanenberg, Robert J.
Cummings, Doyle M.
DIABETES, 2017, 66 : A252 - A252
[30] Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
Roggeri, Daniela Paola
Roggeri, Alessandro
Pengo, Vittorio
FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2014, 15 (04) : 113 - 127

← 1 2 3 4 5 →